Eli Lilly and Company

NYSE:LLY

Drug Manufacturers - General

Healthcare
$1,382.54 -0.95%

-$10.54 today

Market cap
$1.30T
Beta
0.52
P/E (TTM)
39.0
EPS (TTM)
$28.26
Dividend yield
0.59%
52W Low $623.78High $1,182.73

Volume 2.58M

Average 3.19M

LLY Interest Income

Income earned on cash, deposits, and investments held by the company.

Eli Lilly and CompanyNYSE: LLY

Interest Income · Q2 FY2026 · quarter ended Jun 2026

Interest income remains negative

Q2 FY2026 interest income was $0, compared with $40M a year earlier. Trailing-twelve-month interest income was $65M. Over 3 fiscal years it compounded at +34.6% a year.

Context

  • Interest income amounted to 0.2% of revenue in FY2025, down 0.2 pp from a year earlier.
  • Interest income increased in 2 of the last 3 fiscal years.

What to watch

Whether quarterly interest income holds near $0 or moves back toward the trailing-twelve-month quarterly average of $16.25M.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterJun 2026
$0— QoQ
Last fiscal yearDec 2025
$153.3M-12.5% YoY
LTMJun 2026
$65M-64.0% YoY
Interest Income past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter-100.0%——
1 year-12.5%——
3-year CAGR+34.6%——
5-year CAGR——
10-year CAGR——

Interest Income history

USD · from the income statement

Latest · FY2025
153.3M USD
Year-over-year change
-12.5%
4-year CAGR
+56.7%

Interest Income vs competitors

How LLY compares with its peers on the latest reported figures

  • Peers report in different currencies, so interest income is compared through growth and share of revenue rather than absolute size.
  • Its year-over-year change of -64.0% is the lowest of 8, against a peer median of -33.8%.
  • Interest income amounts to 0.1% of revenue for LLY, versus a peer median of 0.6%.
LLY Competitors
Interest Income for LLY and competitors
Company Period LTM YoY 3-year CAGR% of revenue
NVONovo Nordisk A/SLTM Jun 2026DKK 11.65B DKK-17.0%+74.5%3.5%
JNJJohnson & JohnsonLTM Sep 2026$685M USD-37.7%+29.2%0.7%
PFEPfizer Inc.LTM Jun 2026$532M USD-9.1%+33.9%0.8%
AZNAstraZeneca PLCLTM Sep 2026$342.11M USD+13.7%+64.4%0.6%
SNYSanofiLTM Jun 2026€274.69M EUR-50.8%+25.1%0.6%
MRKMerck & Co., Inc.LTM Jun 2026$200M USD-55.7%+29.8%0.3%
ABBVAbbVie Inc.LTM Sep 2026$198M USD-33.8%+12.7%0.3%
LLYEli Lilly and CompanyLTM Jun 2026$65M USD-64.0%+34.6%0.1%
NVSNovartis AGLTM Jun 2026$0 USD—-0.2%0.0%
AMGNAmgen Inc.LTM Jun 2026$0 USD——0.0%
Peer median (excluding LLY) —-33.8%+29.5%0.6%

Competitors are the stored peer set for LLY. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue28.32B28.54B34.12B45.04B65.18B
Cost of Revenue7.31B6.63B7.08B8.42B11.05B
Gross Profit21.01B21.91B27.04B36.63B54.13B
Gross Margin74.2%76.8%79.2%81.3%83.0%
Research & Development6.93B7.19B9.31B10.99B13.34B
Selling, General & Admin6.14B6.07B6.94B8.59B11.09B
Operating Expenses13.07B13.26B16.25B19.59B24.43B
Depreciation & Amortization1.55B1.52B1.53B1.77B2B
EBITDA8.04B8.66B8.57B18.81B31.69B
EBITDA Margin28.4%30.3%25.1%41.8%48.6%
Operating Income7.93B8.65B10.79B17.04B29.7B
Operating Margin28.0%30.3%31.6%37.8%45.6%
Interest Income25.4M62.8M173.6M175.2M153.3M
Interest Expense339.8M331.6M485.9M780.6M795.3M
Other Income / Expenses(1.78B)(1.85B)(4.23B)(4.36B)(3.97B)
Income Before Tax6.16B6.81B6.55B12.68B25.73B
Pre-Tax Margin21.7%23.8%19.2%28.2%39.5%
Income Tax Expense573.8M561.6M1.31B2.09B5.09B
Net Income5.58B6.24B5.24B10.59B20.64B
Net Margin19.7%21.9%15.4%23.5%31.7%
EPS (Basic)5.856.575.8311.7623.07
EPS (Diluted)5.856.575.8011.7122.95
Weighted Avg Shares953.65M950.18M899.38M900.61M898M
Weighted Avg Shares (Diluted)953.65M950.18M903.28M904.06M898M

Eli Lilly and Company

NYSE:LLY

Intrinsic Alpha fair value

Locked

Current Price

$1,382.54

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.